Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TEVA-TAMOXIFEN TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-05-23 219038
TEVA-ESOMEPRAZOLE TEVA CANADA LIMITED Resolved 20MG Updated Report 2024-05-23 221552
TEVA-DONEPEZIL TEVA CANADA LIMITED Resolved 5MG Updated Report 2024-05-23 222941
TEVA-TOPIRAMATE TEVA CANADA LIMITED Resolved 25MG Updated Report 2024-05-23 224889
TEVA-LENOLTEC NO. 3 TEVA CANADA LIMITED Resolved 300MG 30MG 15MG Updated Report 2024-05-23 225477
TEVA-CEPHALEXIN 250 TEVA CANADA LIMITED Resolved 250MG Updated Report 2024-05-23 220977
TEVA-MOMETASONE TEVA CANADA LIMITED Actual shortage 50MCG Updated Report 2024-05-23 215760
TEVA-LACOSAMIDE TEVA CANADA LIMITED Actual shortage 50MG Updated Report 2024-05-23 222575
TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED Actual shortage 2MG 8MG Updated Report 2024-05-23 221537
ACT METHYLPHENIDATE ER TEVA CANADA LIMITED Actual shortage 54MG Updated Report 2024-05-23 228143
TEVA-AMPHETAMINE XR TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2024-05-23 224904
TEVA-DUTASTERIDE TEVA CANADA LIMITED Actual shortage 0.5MG Updated Report 2024-05-23 184216
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 195481
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 195456
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-23 195652
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-23 151465
TEVA-QUETIAPINE XR TEVA CANADA LIMITED Actual shortage 400MG Updated Report 2024-05-23 222572
TEVA-CLOPIDOGREL TEVA CANADA LIMITED Actual shortage 300MG Updated Report 2024-05-23 212720
TEVA-TELMISARTAN HCTZ TEVA CANADA LIMITED Actual shortage 25.0MG 80.0MG Updated Report 2024-05-23 224901
TEVA-CANDESARTAN TEVA CANADA LIMITED Actual shortage 16MG Updated Report 2024-05-23 220267
TEVA-EZETIMIBE TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 222569
TEVA-EZETIMIBE TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 223850
TEVA-IRBESARTAN HCTZ TEVA CANADA LIMITED Actual shortage 300MG 25MG Updated Report 2024-05-23 224898
TEVA-IRBESARTAN HCTZ TEVA CANADA LIMITED Actual shortage 300MG 12.5MG Updated Report 2024-05-23 224895
TEVA-TELMISARTAN TEVA CANADA LIMITED Actual shortage 80MG Updated Report 2024-05-23 223847
TEVA-OMEPRAZOLE TEVA CANADA LIMITED Actual shortage 10MG Updated Report 2024-05-23 217231
ACT ENALAPRIL TEVA CANADA LIMITED Actual shortage 8MG Updated Report 2024-05-23 225486
TEVA-FENTANYL TEVA CANADA LIMITED Actual shortage 50MCG Updated Report 2024-05-23 218137
TEVA-FENTANYL TEVA CANADA LIMITED Actual shortage 25MCG Updated Report 2024-05-23 218132
TEVA-SIMVASTATIN TEVA CANADA LIMITED Actual shortage 40MG Updated Report 2024-05-23 215722
TEVA-SIMVASTATIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2024-05-23 198303
TEVA-NITROFURANTOIN TEVA CANADA LIMITED Actual shortage 100MG Updated Report 2024-05-23 219677
TEVA-IPRATROPIUM STERINEBS TEVA CANADA LIMITED Actual shortage 250MCG Updated Report 2024-05-23 198292
TEVA-DOXYCYCLINE TEVA CANADA LIMITED Actual shortage 100MG Updated Report 2024-05-23 225483
TEVA-SUCRALFATE TEVA CANADA LIMITED Actual shortage 1G Updated Report 2024-05-23 221540
TEVA-CEPHALEXIN 250 TEVA CANADA LIMITED Actual shortage 250MG Updated Report 2024-05-23 227459
UROMITEXAN BAXTER CORPORATION Anticipated shortage 100MG New Report 2024-05-23 228511
THYROGEN SANOFI-AVENTIS CANADA INC Resolved 0.9MG Updated Report 2024-05-23 191764
!T3 LOXAPAC IM SANDOZ CANADA INCORPORATED Anticipated shortage 50MG New Report 2024-05-23 226623
!!T3 XYLAC PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 25MG Updated Report 2024-05-23 222737
!!T3 XYLAC PENDOPHARM DIVISION OF PHARMASCIENCE INC Actual shortage 10MG Updated Report 2024-05-23 226445
COTAZYM ORGANON CANADA INC. Actual shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2024-05-23 225096
KADIAN BGP PHARMA ULC Actual shortage 10MG Updated Report 2024-05-23 228360
MYLAN-VALACYCLOVIR MYLAN PHARMACEUTICALS ULC Actual shortage 1000MG Updated Report 2024-05-23 228372
PMS-SUMATRIPTAN PHARMASCIENCE INC Actual shortage 50MG Updated Report 2024-05-22 222384
PMS-LOSARTAN PHARMASCIENCE INC Actual shortage 25MG Updated Report 2024-05-22 214340
APO-MOMETASONE APOTEX INC Resolved 50MCG Updated Report 2024-05-22 216669
XYLOCAINE 2% W EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 20MG Updated Report 2024-05-22 222670
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 ASPEN PHARMACARE CANADA INC. Anticipated shortage 0.005MG 20MG Updated Report 2024-05-22 220855
EMLA CREAM ASPEN PHARMACARE CANADA INC. Anticipated shortage 2.5% 2.5% Updated Report 2024-05-22 222665

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-18 228249
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 20MG Updated Report 2024-05-18 228256
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED Discontinued 40MG Updated Report 2024-05-18 228263
SANDOZ SENNA S SANDOZ CANADA INCORPORATED Discontinued 50MG 8.6MG Updated Report 2024-05-18 228268
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166